| 國立成功大學 |
2024-09 |
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan
|
Chang;Chin-Wei;Hsu;Wei-Fan;Tseng;Kuo-Chih;Chen;Chi-Yi;Cheng;Pin-Nan;Hung;Chao-Hung;Lo;Ching-Chu;Bair;Ming-Jong;Chen;Chien-Hung;Lee;Pei-Lun;Lin;Chun-Yen;Kuo;Hsing-Tao;Chen;Chun-Ting;Yang;Chi-Chieh;Huang;Jee-Fu;Tai;Chi-Ming;Hu;Jui-Ting;Lin;Chih-Lang;Su;Wei-Wen;Tsai;Wei-Lun;Huang;Yi-Hsiang;Cheng;Chien-Yu;Lin;Chih-Lin;Wang;Chia-Chi;Yang;Sheng-Shun;Mo;Lein-Ray;Chen;Guei-Ying;Chang;Chun-Chao;Wang;Szu-Jen;Huang;Chia-Sheng;Hsieh;Tsai-Yuan;Lin;Chih-Wen;Lee;Tzong-Hsi;Chong;Lee-Won;Huang;Chien-Wei;Chang;Shiuh-Nan;Tsai;Ming-Chang;Hsu;Shih-Jer;Kao;Jia-Horng;Liu;Chun-Jen;Liu;Chen-Hua;Lin;Han-Chieh;Tsai;Pei-Chien;Yeh;Ming-Lun;Huang;Chung-Feng;Dai;Chia-Yen;Chuang;Wan-Long;Yu;Ming-Lung;Peng;Cheng-Yuan |
| 國立成功大學 |
2024-07 |
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
|
Tsai;Pei-Chien;Huang;Chung-Feng;Yeh;Ming-Lun;Hsieh;Meng-Hsuan;Kuo;Hsing-Tao;Hung;Chao-Hung;Tseng;Kuo-Chih;Lai;Hsueh-Chou;Peng;Cheng-Yuan;Wang;Jing-Houng;Chen;Jyh-Jou;Lee;Pei-Lun;Chien;Rong-Nan;Yang;Chi-Chieh;Lo;Gin-Ho;Kao;Jia-Horng;Liu;Chun-Jen;Liu;Chen-Hua;Yan;Sheng-Lei;Lin;Chun-Yen;Su;Wei-Wen;Chu;Cheng-Hsin;Chen;Chih-Jen;Tung;Shui-Yi;Tai;Chi-Ming;Lin;Chih-Wen;Lo;Ching-Chu;Cheng;Pin-Nan;Chiu;Yen-Cheng;Wang;Chia-Chi;Cheng;Jin-Shiung;Tsai;Wei-Lun;Lin;Han-Chieh;Huang;Yi-Hsiang;Chen;Chi-Yi;Huang;Jee-Fu;Dai;Chia-Yen;Chung;Wan-Long;Bair;Ming-Jong;Yu;Ming-Lung |
| 國立成功大學 |
2024-06 |
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Na�ve Patients from a Nationwide HCV Registry in Taiwan
|
Yang;Chun-Chi;Huang;Chung-Feng;Chang;Te-Sheng;Lo;Ching-Chu;Hung;Chao-Hung;Huang;Chien-Wei;Chong;Lee-Won;Cheng;Pin-Nan;Yeh;Ming-Lun;Peng;Cheng-Yuan;Cheng;Chien-Yu;Huang;Jee-Fu;Bair;Ming-Jong;Lin;Chih-Lang;Yang;Chi-Chieh;Wang;Szu-Jen;Hsieh;Tsai-Yuan;Lee;Tzong-Hsi;Lee;Pei-Lun;Wu;Wen-Chih;Lin;Chih-Lin;Su;Wei-Wen;Yang;Sheng-Shun;Wang;Chia-Chi;Hu;Jui-Ting;Mo;Lein-Ray;Chen;Chun-Ting;Huang;Yi-Hsiang;Chang;Chun-Chao;Huang;Chia-Sheng;Chen;Guei-Ying;Kao;Chien-Neng;Tai;Chi-Ming;Liu;Chun-Jen;Lee;Mei-Hsuan;Kuo;Hsing-Tao;Tsai;Pei-Chien;Dai;Chia-Yen;Kao;Jia-Horng;Lin;Han-Chieh;Chuang;Wang-Long;Tseng;Kuo-Chih;Chen;Chi-Yi;Yu;Ming-Lung |
| 國立成功大學 |
2024-06 |
Real-world effectiveness and safety of 8-week glecaprevir/pibrentasvir for treatment-naive patients from Taiwan nationwide HCV registry
|
Huang;Chung-Feng;Chang;Te-Sheng;Kuo;Hsing-Tao;Huang;Chien-Wei;Mo;Lien-Ray;Tai;Chi-Ming;Tseng;Kuo-Chih;Bair;Ming-Jong;Wang;Sih-Ren;Lo;Ching-Chu;Chong;Lee-Won;Cheng;Pin-Nan;Yeh;Ming-Lun;Peng;Cheng-Yuan;Cheng;Chien-Yu;Huang;Jee-Fu;Lin;Chih-Lang;Yang;Chi-Chieh;Hsieh;Tsai-Yuan;Lee;Tzong-Hsi;Lee;Pei-Lun;Wu;Wen-Chih;Lin;Chih-Lin;Su;Wei-Wen;Yang;Sheng-Shun;Wang;Chia-Chi;Hu;Jui-Ting;Chen;Chun-Ting;Huang;Yi-Hsiang;Chang;Chun-Chao;Huang;Chia-Sheng;Chen;Guei-Ying;Kao;Chien-Neng;Liu;Chun-Jen;Lee;Mei-Hsuan;Tsai;Pei-Chien;Dai;Chia-Yen;Kao;Jia-Horng;Lin;Han-Chieh;Chuang;Wan-Long;Hung;Chao-Hung;Chen;Chi-Yi;Yu;Ming-Lung |
| 國立成功大學 |
2024-06 |
Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis
|
Lim;Young-Suk;Choi;Jonggi;Choi;Won-Mook;Kang;Wonseok;Kim;Gi-Ae;Kim;Joon, Hyung;Lee;Jeong-Hoon;Lee;Bin, Yun;Park;Hwa, Neung;Kwon;Young, So;Jang;Sun, Eun;Park;Young, Soo;Kim;Hoon, Ji;Yu;Ming-Lung;Chen;Chien-Hung;Hsu;(Holden), Yao-Chun;Bair;Ming-Jong;Cheng;Pin-Nan;Tung;Hung-Da;Chang;Te-Sheng;Chen;Chi-Yi;Lo;Chingchu;Tseng;Kuo-Chih;Yang;Sheng-Shun;Peng;Cheng-Yuan |
| 國立成功大學 |
2024-04 |
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan
|
Yu;Ming-Lung;Tai;Chi-Ming;Mo;Lein-Ray;Kuo;Hsing-Tao;Huang;Chung-Feng;Tseng;Kuo-Chih;Lo;Ching-Chu;Bair;Ming-Jong;Wang;Szu-Jen;Huang;Jee-Fu;Yeh;Ming-Lun;Chen;Chun-Ting;Tsai;Ming-Chang;Huang;Chien-Wei;Lee;Pei-Lun;Yang;Tzeng-Hue;Huang;Yi-Hsiang;Chong;Lee-Won;Chen;Chien-Lin;Yang;Chi-Chieh;Hung;Chao-Hung;Yang;Sheng-Shun;Cheng;Pin-Nan;Hsieh;Tsai-Yuan;Hu;Jui-Ting;Wu;Wen-Chih;Cheng;Chien-Yu;Chen;Guei-Ying;Zhou;Guo-Xiong;Tsai;Wei-Lun;Kao;Chien-Neng;Lin;Chih-Lang;Wang;Chia-Chi;Lin;Ta-Ya;Lin;Chih-Lin;Su;Wei-Wen;Lee;Tzong-Hsi;Chang;Te-Sheng;Liu;Chun-Jen;Dai;Chia-Yen;Chen;Chi-Yi;Kao;Jia-Horng;Lin;Han-Chieh;Chuang;Wan-Long;Peng;Cheng-Yuan |
| 國立成功大學 |
2024-01 |
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
|
Lu;Ming-Ying;Huang;Chung-Feng;Hung;Chao-Hung;Tai;Chi-Ming;Mo;Lein-Ray;Kuo;Hsing-Tao;Tseng;Kuo-Chih;Lo;Ching-Chu;Bair;Ming-Jong;Wang;Szu-Jen;Huang;Jee-Fu;Yeh;Ming-Lun;Chen;Chun-Ting;Tsai;Ming-Chang;Huang;Chien-Wei;Lee;Pei-Lun;Yang;Tzeng-Hue;Huang;Yi-Hsiang;Chong;Lee-Won;Chen;Chien-Lin;Yang;Chi-Chieh;Yang;Sheng-Shun;Cheng;Pin-Nan;Hsieh;Tsai-Yuan;Hu;Jui-Ting;Wu;Wen-Chih;Cheng;-Yu, Chien;Chen;Guei-Ying;Zhou;Guo-Xiong;Tsai;Wei-Lun;Kao;Chien-Neng;Lin;Chih-Lang;Wang;-Chi, Chia;Lin;Ta-Ya;Lin;Chih-Lin;Su;-Wen, Wei;Lee;Tzong-Hsi;Chang;Te-Sheng;Liu;Chun-Jen;Dai;-Yen, Chia;Kao;Jia-Horng;Lin;Han-Chie;Chuang;-Long, Wan;Peng;Cheng-Yuan;Tsai;Chun-Wei;Chen;Chi-Yi;Yu;Ming-Lung |
